EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Sunitinib resistance in renal cell carcinoma

Christudas Morais

Journal of Kidney Cancer and VHL · 2014

DOI: 10.15586/jkcvhl.2014.7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Kidney Cancer and VHL, 2014. Verfasst von Christudas Morais. Beteiligte Einrichtung: Centre for Kidney Disease Research, School of Medicine, The University of Queensland at Translational Research Institute, Brisbane, Queensland 4102, …. Die Arbeit wurde bisher 63-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Of the many targeted therapies introduced since 2006, sunitinib has carved its way to become the most commonly used first-line therapy for the treatment of metastatic renal cell carcinoma (RCC). Despite significant improvements in progression-free survival, 30% of the patients are intrinsically resistant to sunitinib and the remaining 70% who respond initially will eventually become resistant in 6–15 months. While the molecular mechanisms of acquired resistance to sunitinib have been unravelling at a rapid rate, the mechanisms of intrinsic resistance remain elusive. Combination therapy, sunitinib rechallenge and sequential therapy have been investigated as means to overcome resistance to sunitinib. Of these, sequential therapy appears to be the most promising strategy. This mini review summarises our emerging understanding of the molecular mechanisms, and the strategies employed to overcome sunitinib resistance.

Autor:innen und Institutionen

  • Centre for Kidney Disease Research, School of Medicine, The University of Queensland at Translational Research Institute, Brisbane, Queensland 4102, Australia.

Zitieren

APA

Morais, C. (2014). Sunitinib resistance in renal cell carcinoma. Journal of Kidney Cancer and VHL. https://doi.org/10.15586/jkcvhl.2014.7

Vancouver

Morais C. Sunitinib resistance in renal cell carcinoma. Journal of Kidney Cancer and VHL. 2014. doi:10.15586/jkcvhl.2014.7

BibTeX
@article{Morais2014,
  author = {Morais, Christudas},
  title = {Sunitinib resistance in renal cell carcinoma},
  journal = {Journal of Kidney Cancer and VHL},
  year = {2014},
  doi = {10.15586/jkcvhl.2014.7}
}
Kostenlos starten →